Organogenesis Holdings Inc. declined 6.64% in intraday trading, with the company holding its Second Quarter 2025 Earnings Conference Call. The call, which included operator instructions, may have led to investor uncertainty or dissatisfaction, resulting in the stock's decline.
Comments
No comments yet